Ofatumumab, High Dose Methylprednisolone, Ofatumumab and Lenalidomide Consolidative Therapy for Untreated CLL/SLL
Clinical trial NCT01496976 · COMPLETED
Trial details
- NCT number
- NCT01496976
- Sponsor
- H. Lee Moffitt Cancer Center and Research Institute
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-03-30
- Primary completion
- 2021-10-06
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.